Cargando…
FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism
Alzheimer’s disease (AD) is defined by progressive neurodegeneration, with oligomerization and aggregation of amyloid-β peptides (Aβ) playing a pivotal role in its pathogenesis. In recent years, the yeast Saccharomyces cerevisiae has been successfully used to clarify the roles of different human pro...
Autores principales: | Chen, Xin, Ji, Boyang, Hao, Xinxin, Li, Xiaowei, Eisele, Frederik, Nyström, Thomas, Petranovic, Dina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018843/ https://www.ncbi.nlm.nih.gov/pubmed/32054832 http://dx.doi.org/10.1038/s41467-020-14525-4 |
Ejemplares similares
-
Dataset for suppressors of amyloid-β toxicity and their functions in recombinant protein production in yeast
por: Chen, Xin, et al.
Publicado: (2022) -
Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast
por: Chen, Xin, et al.
Publicado: (2017) -
UBB(+1) reduces amyloid-β cytotoxicity by activation of autophagy in yeast
por: Chen, Xin, et al.
Publicado: (2021) -
Crystal structures of FMN‐bound and FMN‐free forms of dihydroorotate dehydrogenase from Trypanosoma brucei
por: Kubota, Tomomi, et al.
Publicado: (2018) -
Bioenergetic Alterations of Metabolic Redox Coenzymes as NADH, FAD and FMN by Means of Fluorescence Lifetime Imaging Techniques
por: Kalinina, Sviatlana, et al.
Publicado: (2021)